Myopic Monovision: EDOF vs. Monofocal IOL
Launched by VIENNA INSTITUTE FOR RESEARCH IN OCULAR SURGERY · Jan 4, 2022
Trial Information
Current as of May 05, 2025
Unknown status
Keywords
ClinConnect Summary
Spectacle independence is one of the main aims in modern cataract surgery. Although bilateral monofocal IOL implantation, aiming for emmetropia or low myopia, leads to high levels of patient satifsfaction in distance vision, spectacle dependence for reading and other near vision tasks is the usual result.
There are different techniques to reduce spectacle dependence, the most common one is the use of multifocal IOLs. However, a variable number of patients complain of problems, such as glare or haloes. It appears that multifocal IOL technology does lead to less satisfying results in patient...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age-related cataract in both eyes
- • bilateral cataract surgery
- • motivated to be less spectacle dependent in the intermediate to near vision range
- • expected CDVA of 0.8 snellen or better
- • myopic patients with shorter eye having an axial length of at least 25.5 mm
- • age 21 and older
- • planned postoperative astigmatis lower than or 0.75 D
- • written informed consent prior to recruitment
- Exclusion Criteria:
- • pregnancy (pregnancy test will be taken pre-operatively in women of reproductive age)
- • retinitis pigmentosa
- • chronic uveitis
- • amblyopia
- • pupil decentration \> 0.8 mm, pupil size \< 2.8 mm
- • preceded retinal surgery
- • preceded LASIK
- • any ophthalmic abnormality that could compromise visual function or the measurements
About Vienna Institute For Research In Ocular Surgery
The Vienna Institute for Research in Ocular Surgery is a leading clinical research organization dedicated to advancing the field of ophthalmic surgery through innovative research and development. Committed to enhancing patient outcomes and safety, the institute conducts rigorous clinical trials that explore new surgical techniques, devices, and treatment protocols for various ocular conditions. With a multidisciplinary team of experts in ophthalmology, surgery, and medical research, the institute aims to bridge the gap between scientific discovery and clinical application, fostering collaboration with healthcare professionals and industry partners to drive advancements in ocular health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Trial Officials
Oliver Findl, MD
Principal Investigator
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials